Evidence map›Paper›PMID 28018349›Full record

ReviewFrontiers in immunology2016

Allorecognition by T Lymphocytes and Allograft Rejection.

Jose Marino, Joshua Paster, Gilles Benichou

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 1 synthesis or guideline pooled it, 219 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Exosomes as a biomarker in postoperative complications: a literature review.Frontiers in cell and developmental biology · 2026
    Review
  14. Cellular and Molecular Aspects of Chronic Rejection.Results and problems in cell differentiation · 2026
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Best practices of heart transplantation in mice.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Review
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jose MarinoCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School , Boston, MA , USA.
Joshua PasterCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School , Boston, MA , USA.
Gilles BenichouCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School , Boston, MA , USA.
Massachusetts General Hospital · USHarvard University · US

Funding

XENOGENIC TOLERANCE IN MICEP01HL018646 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1985 to 2019
$37.5M
Tolerance to Composite Islet-Kidney Transplants in Non-Human PrimatesU19AI102405 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI COSIMI, A BENEDICT · 2012 to 2016
$7.7M
Mechanisms Underlying Delayed Transplant ToleranceR21AI111191 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2015 to 2016
$471k
B Cells in Tolerance and Chronic Rejection of Monkey Kidney AllograftsR21AI117466 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2017 to 2018
$470k
NHLBI NIH HHS P01 HL018646NIAID NIH HHS R21 AI111191NIAID NIH HHS R21 AI117466NIAID NIH HHS U19 AI102405
6 · The paper itself

Abstract

Recognition of donor antigens by recipient T cells in secondary lymphoid organs initiates the adaptive inflammatory immune response leading to the rejection of allogeneic transplants. Allospecific T cells become activated through interaction of their T cell receptors with intact allogeneic major histocompatibility complex (MHC) molecules on donor cells (direct pathway) and/or donor peptides presented by self-MHC molecules on recipient antigen-presenting cells (APCs) (indirect pathway). In addition, recent studies show that alloreactive T cells can also be stimulated through recognition of allogeneic MHC molecules displayed on recipient APCs (MHC cross-dressing) after their transfer

Indexed as

allograft rejectionallorecognitionexosomesmajor histocompatibility complexregulatory T cellsT cellsT cell tolerance

Identifiers

PMID28018349
PMCPMC5155009
OpenAlexW2562983292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.